Abstract. The efficacy and mechanism of action of fenretinide (4-HPR), a vitamin A analogue, was investigated in a panel of six neuroblastoma cell lines and multicellular tumor spheroids. The latter are three dimensional cell aggregates and as such, a model for micrometastases. In all cell lines, the production of reactive oxygen species (ROS) increased with 163-680% after 1 h of treatment with 4-HPR. In addition, a decrease of the mitochondrial membrane potential of 30-75% was observed after 4 h of incubation with 4-HPR. A 6-12-fold difference was observed between the IC 50 values for cell proliferation and viability between the most sensitive (IMR32) and most resistant (NASS) cell line towards 4-HPR. Flow cytometric analysis showed an increased amount of apoptotic bodies and no cell-cycle arrest. The antioxidant Trolox completely inhibited the accumulation of 4HPR-induced ROS and prevented the 4HPR-associated cytotoxicity. In all neuroblastoma spheroids, 4-HPR induced a complete cytostasis at clinical relevant concentrations (3-10 μM). Immunohistochemical analysis of 4-HPR-treated spheroids showed a decreased staining for proliferation marker Ki-67 and an increased staining for cleaved-PARP, a marker of apoptosis. Our results suggest that 4-HPR might be a promising agent for the treatment of micrometastases and high-risk neuroblastoma.
Introduction
Neuroblastoma is the most common solid extracranial tumor in children. The prognosis for children suffering from neuroblastoma is highly dependent on the age at diagnosis and the stage of the disease. Patients suffering from metastasized neuroblastoma with amplification of the MYCN oncogene, which is found in approximately 25% of primary, predominantly metastasized neuroblastomas, have a very poor prognosis (1) . Current therapy is based on treatment with chemotherapeutic drugs, surgery, treatment with 131 I-metaiodobenzylguanidine ( 131 I-MIBG) and autologous stem cell transplantation. Despite these aggressive therapeutic strategies, the likelihood for survival for patients suffering from highrisk neuroblastoma has not increased significantly over the last 15 years (2,3). Therefore, new and effective therapeutic strategies are being developed to improve prognosis in these patients.
Stage 4s neuroblastoma is characterized by spontaneous regression of the tumor by differentiation. Retinoids are essential regulators of cell growth, differentiation and cell death (4) . All-trans retinoic acid (ATRA) and 13-cis retinoic acid (13-cis-RA) have been shown to induce differentiation and death in neuroblastoma cells (5) . Although treatment with 13-cis-retinoic acid increased the event-free survival in children with advanced-stage neuroblastoma (6) , its use has been restricted by dose-limiting side effects (5) and increased resistance of retinoic acid differentiated cells to chemotherapeutic drugs (7) . Fenretinide (N-(4-hydroxyphenyl) retinamide) (4-HPR) is a synthetic retinoic acid derivate which induced apoptosis rather than differentiation in a variety of tumors (8) (9) (10) (11) .
The precise mechanism underlying the apoptosis-inducing properties of 4-HPR is not yet fully understood. It has been suggested that 4-HPR can induce apoptosis by both retinoic acid receptor (RAR)-dependent and reactive oxygen species (ROS)-dependent pathways (12) (13) (14) (15) . Mitochondrial membrane depolarization, which plays a key role in the process of apoptosis, has been observed in some tumor types treated with 4-HPR (16) . However, it has been reported that 4-HPR did not alter the mitochondrial membrane potential (ΔΨ m ) in neuroblastoma (17) .
It is known that solid tumors require adequate diffusion of nutrients for tumor growth. Spheroids are three dimensional aggregates of cancer cells that, due to their cellular organization, have been shown to resemble in vivo tumors with respect to growth rates and sensitivity towards chemotherapeutic drugs (18) . Most importantly, they resemble micrometastases during the avascular phase of their development (18) , which provides the opportunity to study phenomena such as the penetration and effectiveness of cytotoxic agents on spheroid size. So far, the effect of 4-HPR has not been studied on a panel of neuroblastoma multicellular spheroids combined with immunohistochemical evaluation. In this report, we describe the effect of 4-HPR on various biological parameters in a panel of MYCN-single copy and MYCNamplified neuroblastoma cell line monolayers as well as spheroids.
Materials and methods
Chemicals. 4-HPR (Sigma, St. Louis, MO, USA), was dissolved in 100% ethanol, stored at 4˚C and protected from light. Serial dilutions were prepared from the stock solution with growth medium just before use. H 2 O 2 (Sigma) was prepared as a 100 μM stock solution in double distilled H 2 O immediately before use. Trolox (Sigma) was prepared as a 0.5 M stock solution in 100% ethanol and kept at -20˚C for one month.
Cell culture. Three MYCN single copy neuroblastoma cell lines (FISK, NASS, SY5Y) and three MYCN amplified neuroblastoma cell lines (IMR32, SJ8, SJNB10) were cultured in RPMI-1640 culture medium (Gibco, Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat inactivated fetal bovine serum, 50 U/ml penicillin/streptomycin and 4 mM glutamine. Cells were grown at 37˚C, 5% CO 2 in 95% humidified air, all culture flasks and plates were from Corning (Corning, NY, USA). All cell lines were a generous gift of Professor R. Versteeg (Department of Human Genetics, Academical Medical Centre, Amsterdam).
Spheroids were prepared by growing 400,000 cells in 4 ml culture medium in an ultra-low attachment sterile Petri dish. Because the cells could not adhere to the bottom of the dish they cohered, forming small aggregates. After three days, small spheroids (0.3-0.5 mm) were formed and these were individually transferred to ultra-low attachment 24-well plates. One well contained one spheroid in 1 ml culture medium. Spheroids were treated with different concentrations 4-HPR for three weeks, without changing the culture medium. The experiments were performed in quadruplicate. Spheroid size was monitored weekly by measurement of the cross-sectional area of individual spheroids five-times magnified photos using a microscope (19) (microscope: Leica DMIL, Wetzlar, Germany. camera: SV camera, Lambert instruments, Leutingewolde, The Netherlands, Image Pro Plus 4.1).
Measurement of cell viability and proliferation. Cells were plated in 96-well plates at a density of 5,000 or 6,500 cells per cell line per well in a total volume of 100 μl and were allowed to adhere overnight, after which the medium was replaced by medium containing different concentrations 4-HPR (0-40 μM). After 24, 48 and 72 h medium with 4-HPR was changed for fresh medium and the viability of the cells was measured with MTS assay (Promega, Madison, WI, USA) according to the manufacturer's protocol. MTS incubation lasted for 4 h at 37˚C. The effect of the antioxidant trolox on viability was investigated by incubating the cells with 4-HPR (5 and 10 μM) and/or trolox (500 μM) for 72 h followed by the MTS assay. Cell proliferation was measured using a 5-bromo-2'-deoxyuridine (BrdU) incorporation assay (Roche Applied Science, Penzberg, Germany), according to the manufacturer's instructions. Cells were incubated for 2 h at 37˚C with BrdU labeling solution, without refreshing the medium. The experiments were performed in quadruplicate. The dose-absorption curves were used to derive the IC 50 values.
Cell cycle analysis. Apoptosis was evaluated by flow cytometry of propidium iodide (PI) stained cells. Cells (500,000) were grown in 4 ml culture medium in a 25 cm 2 flask and treated with 4-HPR (1-5 μM) for 24, 48 and 72 h. Both attached and floating cells were harvested and fixed in 70% ethanol in PBS and stored at 4˚C. For flow cytometric analysis samples were centrifuged at 1000 x g for 1 min. Cell pellets were resuspended in 200 μl PBS after which 200 μl RNAse-PBS in a 4-mg/ml concentration was added. Cells were stained with 400 μl PI-saponin (0.05 mg PI/ml 0.02% (w/v) (saponin-PBS), vortexed thoroughly and incubated for 10 min at 37˚C. The stained cell nuclei were analyzed by a FACS Calibur flow cytometer (Beckton-Dickinson) and the data were analyzed using WinMD1 version 2.8 software.
Measurement of apoptosis -PARP analysis. Cells (750,000) were cultured in 4 ml in a 25 cm 2 flask and allowed to adhere overnight, after which the medium was replaced by medium containing 4-HPR (0-20 μM). After 24 h, both attached and floating cells were collected and centrifugated and the pellet was resuspended in PBS, sonicated (2x20 s, 8 W) and boiled (5 min). Protein concentrations were detected using a BCA protein determination assay (20) . Samples were diluted to equal protein concentrations in sample buffer.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis was performed as described by Laemmli (21) followed by Western blotting using the primary mouse anti-human poly (ADP-ribose) polymerase (PARP) monoclonal antibody 1:10,000 diluted (Biomol, UK) and rabbit anti-mouse secondary antibody in a 1:5,000 dilution in PBS containing 3% BSA and 0.01% Tween-20 conjugated with horseradish peroxidase. After washing the membrane, detection of PARP was performed with enhanced chemiluminescence. Equal loading was confirmed using Ponceau S staining (22) . Neuroblastoma cells treated with the histone deacetylase inhibitor BL1521 were used as a positive control (23) .
Immunohistochemistry. Spheroids were immersion fixed in buffered formalin and embedded in paraffin. Dewaxed and rehydrated sections (4.5 μm thick) were stained with hematoxylin and eosin (H&E) for morphology. Endogenous peroxidases were blocked with 3% hydrogen peroxide. After antigen retrieval (microwaving, Tris-EDTA) aspecific binding was prevented by blocking with 5% normal goat serum. Apoptosis was detected using anti-cleaved-PARP 1:200 (BD Biosciences, USA), proliferation was detected using anti-Ki-67 1:200 (Dako, M7240), both incubated 1 h at room temperature. Sections were blocked using post-antibody blocking (Immunologic) for 15 min at room temperature. Sections were incubated with biotinylated secondary poly-HPR anti-rabbit/mouse antibodies and avidin-biotin complex (Vectastain ABC Kit). Immunoreactivity was visualized by incubation with 3,3'-diaminobenzidine (Sigma), tissues were counterstained with hematoxylin QS (Vector laboratories, USA). Sections were dehydrated, cleared in HistoClear II and mounted in DPX mounting for histology (Fluka, St. Louis, MO, USA). For negative controls primary antibodies were omitted. Sections were examined using a Zeiss microscope and photographed using a Leica camera.
Reactive oxygen species (ROS). ROS production was detected using CM-H 2 DCFDA (Invitrogen, Molecular Probes). Cells (100,000) were cultured in 1 ml medium in 12-well plates and allowed to adhere overnight. Subsequently, cells were treated with a concentration range of 4-HPR (0-10 μM) for 1, 2, 3, 6 and 24 h. The ROS responsive dye CM-H 2 DCFDA was prepared in DMSO in a 5-μM stock solution and kept on ice until use. Culture medium was replaced by 0.8 ml freshly prepared CM-H 2 DCFDA-solution and incubated at 37˚C for 15 min. Subsequently, fluorescence was measured in a microplate reader (BMG Labtech, FLUOstar Optima); excitation 485 nm, emission 520 nm. Cells were harvested by trypsinization and protein determination was performed using bicinchoninic acid (BCA) reagens (Sigma) according to the manufacturer's protocol using bovine serum albumin (BSA) as a standard. ROS production was also measured after incubating the cells for 4 h with 20 μM 4-HPR and/or trolox (500 μM).
Mitochondrial membrane potential (ΔΨ m )
. Cells (200,000) were cultured in 1 ml culture medium in 12-well plates and allowed to adhere overnight. Subsequently, medium was replaced by medium containing different concentrations of 4-HPR (0-20 μM). After 4-h incubation with 4-HPR, medium was replaced by medium containing 10 μg/ml JC-1 (Invitrogen, Molecular Probes). After a 15-min incubation at room temperature, the cells were washed with 500 μl PBS and the ratio of monomeric form and aggregates was measured in a microplate reader (BMG Labtech, FLUOstar Optima); excitation 485 nm, emission 520 nm and 600 nm. In addition, the mitochondrial membrane potential was measured using 4 μM TMRM (Invitrogen). Fluorescence was measured with excitation A550 nm and emmision A600 nm.
Statistical analyses. Differences in viability between MYCN amplified and MYCN single copy cell lines were analysed using the two sample t-test (SPSS 14.0.2). To investigate whether this decrease in viability and proliferation was associated with apoptosis, cell cycle studies with 4-HPR treated cells were performed (Fig. 1) . A substantial amount of cells in sub-G1 phase were detected after incubation with 4-HPR, which indicates DNA condensation and thus apoptosis. No cell cycle arrest was observed. In addition to cell cycle experiments, the presence or absence of cleaved PARP was studied. In all cell lines, 50% of PARP was cleaved at a 4-HPR concentration lower or equal compared to the IC 50 concentration derived from the viability and the proliferation assay (data not shown).
Results
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Effect of 4-HPR on neuroblastoma spheroids.
Spheroids grown from each cell line were treated for three weeks with a concentration range of 4-HPR (0-10 μM). The spheroid size was monitored weekly by photo-imaging. The cross-sectional area of untreated spheroids increased exponentially in time. In contrast, spheroids showed a complete cytostasis when treated with high 4-HPR concentrations (Fig. 2) . The sensitivity for 4-HPR in spheroids is similar to the sensitivity observed in monolayer, with the exception of NASS, which was ~10 times more sensitive when treated as a spheroid. An unexpected finding was that in SJNB10 and SY5Y spheroids, treated with low concentrations 4-HPR, an increased area was observed with respect to the untreated control spheroids (Fig. 2B) .
Microscopical examination of H&E stained sections of untreated IMR32 spheroids showed an organized pattern of an outer proliferative rim and an inner apoptotic core. In the rim of untreated spheroids rosettes were visible, which are histologically typical for neuroblastoma (Fig. 3A) . Apoptosis was observed by the presence of both picnosis and fragmented nuclei. In 4-HPR treated spheroids, a looser cell-cell structure and a decreased amount of cells were observed (Fig. 3A) . Immunohistochemical sections of IMR32 spheroids were stained with an apoptotic marker, PARP, and a proliferation marker, Ki-67. Treatment with 4-HPR (10-20 μM, ------------------------------------------------ 
1 week) showed a dose-dependent decrease in proliferation (Fig. 3B) and a dose-dependent increase in apoptotic cells (Fig. 3C) .
Analysis of ROS and the mitochondrial membrane potential (ΔΨ m )
. In all six cell lines, a dose-dependent increase of ROS production was observed from 1 until 6 h of incubation with 4-HPR (Fig. 4) . The production of ROS increased with 482-680% after 1 h of treatment with 4-HPR in IMR32, SJ8, SJNB10 and SY5Y. In contrast, FISK and NASS showed only a modest increase in ROS (maximum increase was 212 and 163%, respectively) after treatment with 4-HPR. In the presence of the antioxidant Trolox, no accumulation of 4-HPRinduced ROS occurred and trolox prevented the onset of 4HPR-induced cytotoxicity in all cell lines, except FISK (Fig. 5) .
The fluorescent dye, JC-1, accumulates in mitochondria in the presence of a normal ΔΨ m and forms reversible aggregates (Fig. 6A) . In case of a decreased ΔΨ m , JC-1 aggregates dissociates into the monomeric JC-1 molecule (Fig. 6B) . In all cell lines, a similar dose-dependent decrease of the ΔΨ m was observed after a 4-h incubation with 4-HPR (Fig. 6C) , these results were confirmed by a second probe, TMRM (data not shown). This indicates a disturbance of the ΔΨ m induced by 4-HPR, which could result in increased ROS production. The decrease in ΔΨ m does not correlate with the degree of ROS production.
Discussion
The synthetic retinoid 4-HPR has been shown to have a promising preventative effect in recurrence of breast cancer, because of its apoptosis-inducing effect (24) . A phase I study performed in neuroblastoma showed that 4-HPR toxicity was moderate when compared to other retinoids (25, 26) . Until now, most investigations of 4-HPR in neuroblastoma have been restricted to one or a few cell lines and only in monolayers. Due to the heterogenity of neuroblastoma, we have investigated the effectiveness of 4-HPR in vitro in a panel of six neuroblastoma cell lines. No significant difference was observed in sensitivity towards 4-HPR in MYCN amplified and MYCN single copy cell lines. This is in contrast with Reynolds et al (27) and Wei et al (28) who suggested a positive correlation between MYCN amplification and sensitivity to 4-HPR in neuroblastoma. The effective concentrations of 4-HPR inducing cytotoxicity in all cell lines were comparable with achievable plasma concentrations in vivo. In all cell lines treated with 4-HPR, apoptosis was detected by accumulation of apoptotic bodies in the sub G1-phase by flow cytometry and by PARP-cleavage. However, no cell cycle arrest was observed in 4-HPR treated neuroblastoma cells. In ovarian cancer cells, 4-HPR induced a G2 arrest which was ascribed to the formation of 4-oxo-4-HPR from 4-HPR (29) . Therefore, the fact that no cell cycle arrest was observed in neuroblastoma cells might indicate that 4-HPR is not metabolized to 4-oxo-4-HPR in neuroblastoma cells.
The production of ROS has been described in various tumor cell types following exposure to 4-HPR (30) (31) (32) . ROS production has been measured in neuroblastoma with 4-HPR and peak production was observed after 6 h (17,30,33-35) . We observed ROS production already after 1 h of 4-HPR incubation, indicating that ROS production is an early event in response to 4-HPR incubation. Levels of ROS production correlated with the sensitivity of 4-HPR measured in the viability assays, with the exception of FISK, being sensitive to 4-HPR while producing only low levels of ROS. Trolox was able to prevent the accumulation of ROS and the loss of viability due to 4-HPR in all cell lines although the protection was suboptimal in FISK. Thus, in FISK another mechanism, apart from oxidative stress, might be responsible for the induction of apoptosis by 4-HPR. Although, the exact mechanism of ROS induction of 4-HPR is still unknown, oxidative stress appears to be one of the main apoptosis inducing mechanisms.
Since the ROS producing effect proved to be very fast it is conceivable that 4-HPR interferes directly with the mitochondrial respiratory chain (32) . Apoptosis may occur when the amount of ROS produced in the mitochondria cannot be handled by radical-scavenging antioxidants (32) . In contrast, some studies suggested that ceramide and gangliosides were essential in the induction of ROS via 12-LOX (30, 36, 37) . Previously, it was shown that 4-HPR did not alter the ΔΨ m in the neuroblastoma cell line SY5Y (17) . However, in our study a profound decrease in the ΔΨ m was observed in all six cell lines after a 4-h incubation with 4-HPR. This decrease in the ΔΨ m might lead to cytochrome c release, and other mitochondrial enzymes, which in turn will activate caspase 9 to initiate the downstream processes of apoptosis.
For the first time, the effect of 4-HPR on multicellular tumor spheroids was studied in a panel of neuroblastoma cell lines combined with histological analysis of immunostained sections. In 4-HPR-treated spheroids of all six cell lines growth retardation and even cytostasis at higher concentrations was observed. However, SJNB10 and SY5Y spheroids treated with low concentrations (2 μM) 4-HPR showed an increase in cross-sectional area compared to the controls. As shown by Marengo et al, ROS can stimulate cell proliferation when present in very low doses (38) . Thus, it is conceivable that a small increase in ROS produced by low concentrations of 4-HPR might result in increased growth in these spheroids compared to controls. Our results indicated an altered cell-cell structure in 4-HPR treated spheroids. This mechanism might also explain the increased area in spheroids treated with low concentrations of 4-HPR. Nutrients might penetrate more easily due to the open structure allowing cells in the core of the spheroid to proliferate as well. Histological sections stained with an apoptosis marker, anti-cleaved-PARP and a proliferation marker, anti-Ki67 showed a concentrationdependent increase of apoptosis after 1 week of treatment with 4-HPR as well as a decrease in proliferation. Thus, the observed cytostasis (Fig. 2) is a result of decreased proliferation and induction of apoptosis and probably not a cell cycle arrest. Our results are in contrast with studies by Myatt et al who did not observe significant changes in the proliferation pattern in Ewing sarcomas (39) . It is known that 4-HPR also has an anti-angiogenesis effect on neuroblastoma cells (40) . In this way, 4-HPR prevents further development of micrometastases (41) . Taken together, the cytotoxic effects of 4-HPR on avascular spheroids and the anti-angiogenesis effect, suggest that 4-HPR might be an effective chemotherapeutic drug for the treatment of micrometastases of different sizes.
Our investigations have shown that 4-HPR induced loss of the mitochondrial membrane potential and ROS accumulation in neuroblastoma cell lines, which is accompanied by a strong induction of apoptosis. The potency of 4-HPR to induce cytotoxicity in neuroblastoma monolayers and spheroids suggest that 4-HPR might be a promising new agent in treatment of neuroblastoma.
